Alendronate sodium
Catalog No.
A8359
Osteoclast-mediated bone resorption inhibitor
Featured Products
Osteoclast-mediated bone resorption inhibitor. Binds and blocks farnesyl diphosphate synthase (FPPS) in the HMG-CoA pathway (IC50 = 460 nM for recombinant human FPPS); causes macrophage apoptosis. Inhibits prenylation and sterol biosynthesis in purified osteoclasts.
| Physical Appearance | A solid |
| Storage | Desiccate at -20°C |
| M.Wt | 271.08 |
| Cas No. | 129318-43-0 |
| Formula | C4H12NNaO7P2 |
| Synonyms | Fosamax |
| Solubility | insoluble in DMSO; insoluble in EtOH; ≥15 mg/mL in H2O with gentle warming |
| Chemical Name | sodium;(4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate |
| SDF | Download SDF |
| Canonical SMILES | C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+] |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
Chemical structure
